News Daily News New AF Guideline Emphasizes Early Rhythm Control, Elevates Ablation and LAAO Todd Neale November 30, 2023
News Daily News Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs Michael O'Riordan November 27, 2023
News Conference News AHA 2023 Etripamil Nasal Spray Shows Promise for AF Patients With Rapid Ventricular Rate Todd Neale November 16, 2023
Presentation AHA 2023 The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation Presenter: Jeff Healey November 16, 2023
News Conference News AHA 2023 NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear L.A. McKeown November 12, 2023
News Conference News AHA 2023 ARTESiA: Apixaban Lowers Stroke Risk in Subclinical AF Todd Neale November 12, 2023
News Conference News AHA 2023 Off-label DOAC Dosing Common in Hospitalized AF Patients, Too Todd Neale November 07, 2023
News Conference News EACTS 2023 Combined Surgical and Catheter Ablation Best for Persistent AF Michael O'Riordan October 12, 2023
News Daily News One-Third of Patients With AF After Surgery or Illness Have Recurrences Michael O'Riordan October 02, 2023
News Daily News ‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF L.A. McKeown September 18, 2023
News Conference News ESC 2023 New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground Caitlin E. Cox August 30, 2023
News Conference News ESC 2023 FRAIL-AF: Warfarin Beats NOACs in Frail Elderly With AF Shelley Wood August 28, 2023
News Conference News ESC 2023 NOAH-AFNET 6: Edoxaban for Atrial High-Rate Episodes: No Help, Some Harm Todd Neale August 25, 2023